X

Trial Profile

Budesonide/formoterol vs budesonide vs formoterol in patients with mild-to-moderate asthma with or without fixed airway obstruction

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 29 May 2013

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Budesonide/formoterol (Primary) ; Budesonide; Formoterol
Indications Asthma
Focus Therapeutic Use
Acronyms SPRUCE 80/4.5
Sponsors AstraZeneca

Most Recent Events

22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
15 Mar 2012 New trial record
06 Mar 2012 Results assessing efficacy in patients with versus without fixed airflow obstruction presented at the 68th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com